Please login to the form below

Not currently logged in
Email:
Password:

NKTR-102

This page shows the latest NKTR-102 news and features for those working in and with pharma, biotech and healthcare.

Nektar hit by breast cancer trial setback

Nektar hit by breast cancer trial setback

The development is also particularly disappointing for Nektar as NKTR-102 was a wholly owned project. ... Nektar said it would explore with regulators in the US and EU whether there is still a route to market for NKTR-102.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics